Glivec (imatinib mesylate) in the treatment of polycythemia vera

Trial Profile

Glivec (imatinib mesylate) in the treatment of polycythemia vera

Phase of Trial: Phase II

Latest Information Update: 07 Oct 2014

At a glance

  • Drugs Imatinib (Primary)
  • Indications Polycythaemia vera
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jun 2012 Actual patient number is 9 according to
    • 18 Jun 2012 Actual end date (Feb 2010) added as reported by
    • 18 Jun 2012 Status changed from recruiting to discontinued as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top